Please Wait.....
Report
Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Type (Autologous Stem Cells, Autologous Non-Stem Cells), Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, Research Facilities), and Region 2023-2028
Market Report I 2023-05-29 I 144 Pages I IMARC Group
Market Overview:
The global autologous stem cell and non-stem cell based therapies market size reached US$ 6.73 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.39 Billion by 2028, exhibiting a growth rate (CAGR) of 13.60% during 2023-2028. The increasing prevalence of life-threatening diseases, the expanding geriatric population, and ongoing advancements in stem cell technologies represent some of the key factors driving the market.
Autologous stem cell therapy is a medical procedure in which a patient's stem cells are used to repair damaged tissues and organs or treat various diseases. The procedure involves harvesting stem cells from a patient's body, usually from bone marrow or adipose tissue, and then processing and injecting them back into the body. Non-stem cell-based therapies, on the other hand, involve using cells that are not stem cells, such as immune cells, fibroblasts, and muscle cells, to repair or regenerate damaged tissues or organs. Autologous stem cell therapy is used to treat cardiovascular diseases, neurodegenerative diseases, and autoimmune disorders, while non-stem cell-based therapies are employed in treating chronic wounds, heart disease, and Parkinson's disease.
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends:
The growth of the global autologous stem cell and non-stem cell based therapies market is primarily driven by the increasing prevalence of cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases due to smoking, poor diet, and sedentary lifestyles of consumers. Besides this, the rising geriatric population and the growing demand for autologous stem and non-stem cell based therapies are creating a positive outlook for the market. Moreover, the ongoing development of innovative autologous stem cell therapies for regenerative medicine and the widespread demand for personalized therapies are presenting remunerative growth opportunities for the market. In addition to this, the surging popularity of minimally invasive treatments, the expanding acceptance of stem cell therapies, and the implementation of favorable government initiatives, such as financial and regulatory support for stem cell research, are aiding in market expansion. Furthermore, continuous advancements in stem cell technologies have enabled researchers to better control the differentiation of stem cells and develop improved and effective treatments, which, in turn, is acting as a significant growth-inducing factor. Besides this, the bolstering growth of the healthcare sector, extensive research and development (R&D) activities, the escalating health consciousness among consumers, and favorable reimbursement policies are contributing to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global autologous stem cell and non-stem cell based therapies market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type, application, and end user.
Type Insights:
Autologous Stem Cells
Autologous Non-Stem Cells
The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the type. This includes autologous stem cells and autologous non-stem cells. According to the report, autologous stem cells represented the largest segment.
Application Insights:
Cancer
Neurodegenerative Disorders
Cardiovascular Disease
Orthopedic Diseases
Others
A detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the application has also been provided in the report. This includes cancer, neurodegenerative disorders, cardiovascular disease, orthopedic diseases, and others. According to the report, cancer accounted for the largest market share.
End User Insights:
Hospitals
Ambulatory Surgical Centers
Research Facilities
The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the end user. This includes hospitals, ambulatory surgical centers, and research facilities. According to the report, hospitals represented the largest segment.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for autologous stem cell and non-stem cell based therapies. Some of the factors driving the North America autologous stem cell and non-stem cell based therapies market included the expanding prevalence of chronic diseases, the rising demand for personalized medicines, and continuous advancements in stem cell technologies.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global autologous stem cell and non-stem cell based therapies market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include BrainStorm Cell Limited, Cytori Therapeutics Inc., Holostem Terapie Avanzate S.r.l., Lisata Therapeutics, U.S. Stem Cell Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global autologous stem cell and non-stem cell based therapies market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global autologous stem cell and non-stem cell based therapies market?
What is the impact of each driver, restraint, and opportunity on the global autologous stem cell and non-stem cell based therapies market?
What are the key regional markets?
Which countries represent the most attractive autologous stem cell and non-stem cell based therapies market?
What is the breakup of the market based on the type?
Which is the most attractive type in the autologous stem cell and non-stem cell based therapies market?
What is the breakup of the market based on the application?
Which is the most attractive application in the autologous stem cell and non-stem cell based therapies market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the autologous stem cell and non-stem cell based therapies market?
What is the competitive structure of the global autologous stem cell and non-stem cell based therapies market?
Who are the key players/companies in the global autologous stem cell and non-stem cell based therapies market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Autologous Stem Cells
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Autologous Non-Stem Cells
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Neurodegenerative Disorders
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cardiovascular Disease
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Orthopedic Diseases
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Research Facilities
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 BrainStorm Cell Limited
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Cytori Therapeutics Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Holostem Terapie Avanzate S.r.l.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Lisata Therapeutics
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 U.S. Stem Cell Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT AnalysisKindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Figure 1: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Major Drivers and Challenges
Figure 2: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Type (in %), 2022
Figure 5: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Application (in %), 2022
Figure 6: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by End User (in %), 2022
Figure 7: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Region (in %), 2022
Figure 8: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Stem Cells) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Stem Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Non-Stem Cells) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Non-Stem Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Neurodegenerative Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Neurodegenerative Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cardiovascular Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Orthopedic Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Orthopedic Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Research Facilities) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Research Facilities) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Drivers, Restraints, and Opportunities
Figure 78: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Value Chain Analysis
Figure 79: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Porter's Five Forces Analysis
Table 1: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Competitive Structure
Table 7: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security